PHI 18/17 Guidelines for evaluation of Transcatheter Aortic Valve Implantation (TAVI) or Transcatheter Aortic Valve Replacement (TAVR) devices

Page last updated: 28 April 2017

PDF version: PHI 18/17 Guidelines for evaluation of Transcatheter Aortic Valve Implantation (TAVI) or Transcatheter Aortic Valve Replacement (TAVR) devices (PDF 46 KB)

The new clinical guidelines for the evaluation of Transcatheter Aortic Valve Implantation (TAVI) or Transcatheter Aortic Valve Replacement (TAVR) devices are now available on the Department’s website.

The Prostheses List Advisory Committee (PLAC) has endorsed these guidelines.

They are an addendum to the Clinical Evidence Requirements for new applications contained in the Prostheses Guide, also available on the Department’s website.